Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Gadolinium Market size was USD 6.1 billion in 2024 and is estimated to reach USD 12.5 billion by the end of 2037, expanding at a CAGR of 5.8% during the forecast period, i.e., 2025-2037. In 2025, the industry size of gadolinium is assessed at USD 6.4 billion.
Gadolinium’s strong neutron-absorbing quality is augmenting its development in nuclear applications. Continuous innovations in nuclear technologies are amplifying the consumption of gadolinium components. In the coming years, gadolinium is poised to find wide applications in the manufacturing of nuclear reactors and nuclear energy generation. The increasing use of nuclear plants for cleaner energy production is expected to uplift gadolinium's role in offering improved efficiency and reliability. For instance, the World Nuclear Association study reveals that nuclear energy accounts for 9.0% of the world's electricity share and is the 2nd largest low-carbon power, globally. The nuclear energy utilized across over 50 countries is in about 220 research reactors. Overall, the nuclear energy field is a high-earning marketplace for gadolinium manufacturers.
Being a specialized radioactive element, gadolinium trade is witnessing positive growth around the globe. Enhancing magnetic properties drives the use of gadolinium in turbines for enhanced energy production. For instance, the report by the Observatory of Economic Complexity (OEC) states that the global trade of special radioactive elements including curium, gadolinium, einsteinium, actinium, californium, radium, polonium, and uranium stood at USD 128.0 million in 2023. The export and import trade of these special radioactive elements is concentrated in the Netherlands, with a total export trade of USD 39.0 million and import of USD 18.8 million. Thus, the rising demand for specialized radioactive elements is underscoring a lucrative gadolinium market, worldwide.

Gadolinium Market: Growth Drivers and Challenges
Growth Drivers
- Growing adoption in medical imaging technologies: Gadolinium is finding emerging applications in medical imaging technologies as a contrast agent. Technological advancements in imaging systems and the increasing popularity of non-invasive diagnostic tools are driving the sales of gadolinium components. The increasing prevalence of chronic diseases such as cancer, neurological conditions, and cardiovascular disease coupled with a swiftly rising geriatric population is fueling the demand for advanced imaging technologies and subsequently the consumption of gadolinium. For instance, Research Nester’s study estimates that the global diagnostic imaging devices market is expected to increase from USD 49.9 billion in 2025 to USD 59.2 billion by 2029.
- EV and batteries to boom gadolinium trade: The increasing popularity of zero-emission vehicles is propelling the demand for gadolinium components. This specialized material is used in electric batteries for the production of high-performance magnetic reactions. The energy storage systems such as high-performance batteries and supercapacitors are widely exploring the use of gadolinium. The rising electric vehicle sales are anticipated to propel the gadolinium consumption in batteries. For instance, the International Energy Agency (IEA) report estimates that global electric vehicle (EV) sales crossed 17 million in 2024. The same source also states that the EV battery demand surpassed 750 GWh in 2023, a 40.0% rise from than previous year.
Challenges
- Health concerns on excess gadolinium exposure: In applications, particularly as a contrast agent in imaging technologies, the use of gadolinium is expected to lead to various side effects. Several healthcare studies suggest that individuals or patients who undergo multiple magnetic resonance imaging (MRI) scans are estimated to experience long-term effects of gadolinium. This health concern is increasing the regulatory pressure on the use of gadolinium and ultimately hampering its sales growth to some extent.
- Regulations surrounding mining & extraction activities: The strict regulations on mining activities pose a major challenge for gadolinium manufacturers. Extraction of rare earth element gadolinium causes environmental concerns. High mining activities contaminate the ecosystems leading to large waste generation and chemical use. Limitation on mining extraction in certain regions and scarcity of gadolinium is expected to limit the revenue growth of the key gadolinium market players.
Gadolinium Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
5.8% |
Base Year Market Size (2024) |
USD 6.1 billion |
Forecast Year Market Size (2037) |
USD 12.5 billion |
Regional Scope |
|
Gadolinium Segmentation
Type (Gadolinium Acetate, Gadolinium Acetylacetonate, Gadolinium Oxide, Gadolinium Nitrate, Gadolinium Chloride, Others)
The gadolinium oxide segment is poised to account for a dominating gadolinium market share throughout the study period. The versatility of gadolinium oxide is fueling its applications in diagnostic systems, solar cells, and energy storage systems. The rising trade of end use products is set to have a direct influence on the consumption of gadolinium oxide. Being a rare earth element, gadolinium is found adequately on the earth's crust and its price also contributes to derivatives sales growth. For instance, the Research Nester’s study underscores that the gadolinium oxide price is estimated to reach 187,500 Renminbi per metric ton by 2030.
Application (Electronics, Medical Equipment, Imaging Agents, Nuclear Reactors, Others)
Electronics segment is anticipated to capture over 38.4% gadolinium market share by 2037. Gadolinium the rare earth element is utilized in several electronic components including lasers, phosphors, and semiconductors owing to its unique magnetic capabilities. The increasing demand for advanced electronic products such as improved hard disk drives and flat panel displays in TVs, computers, and laptops further promotes the use of gadolinium. The fueling adoption of electronics and telecommunication devices is poised to uplift the overall gadolinium market growth in the years ahead. The report of Research Nester on the global electronics and smart devices market estimates that the revenue generation is projected to reach a valuation of USD 2.0 trillion by 2037-end, registering a high compound annual growth of 7.2%.
Our in-depth analysis of the global gadolinium market includes the following segments:
Type |
|
Application |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportGadolinium Industry - Regional Scope
North America Market Forecast
North America in gadolinium market is expected to account for more than 42.4% revenue share by the end of 2037. The strong presence of advanced healthcare facilities and continuous advancement in medical diagnosis technologies is primarily fueling gadolinium sales. The electric vehicle trend and increasing importance of renewable energy systems are foreseen to double the revenues of gadolinium manufacturers in the years ahead. The U.S. and Canada with the existence of leading end users are backing the overall sales of gadolinium.
In the U.S., the growing popularity and registrations of zero-emission vehicles are set to increase the demand for gadolinium. Innovations in energy storage systems and the integration of advanced materials are poised to propel the sales of gadolinium and its derivatives. For instance, the IEA study highlights that the U.S. holds a dominating share in global EV sales. The same source also reveals that the U.S. and Europe are leading markets for electric vehicle batteries and are increasing at 40% YoY growth. In the year 2023, the electrical vehicle battery demand stood at around 99 GWh.
Canada’s increasing focus on nuclear power generation is expected to offer lucrative opportunities for gadolinium producers. In the years ahead, the growing importance of renewable energy solutions and investments in nuclear energy generation plants are set to uplift the overall gadolinium market growth. For instance, according to the Canadian Nuclear Safety Commission currently, there are 4 active plants in 2 provinces housing 22 nuclear power reactors and contributing to around 15.0% of the total electricity production. The top nuclear energy generating plants are Bruce Nuclear Generating Station, Pickering Nuclear Generating Station, and Darlington Nuclear Generating Station operating in Ontario, and Point Lepreau Generating Station in New Brunswick.
Asia Pacific Market Statistics
The Asia Pacific gadolinium market is estimated to increase at the fastest CAGR throughout the assessed period. The expanding industrial activities in the region are primarily driving the overall sales of gadolinium. The rise in foreign direct investments and favorable government policies in terms of renewable energy production is further backing the gadolinium trade. The electric vehicle production and supply are set to substantially influence the consumption of gadolinium in China, India, Japan, and South Korea.
China’s dominance in the electric vehicle market is likely to push the sales of gadolinium and its derivatives. The country is consistently influencing overall zero-emission vehicle sales by majorly focusing on production. The innovations in EV and energy storage batteries are promoting the consumption of gadolinium components. For instance, the IEA report states that in the first quarter of 2024, Chinese electric car sales reached 1.9 million. In 2023, the EV battery demand in China stood at 417 GWh.
The rapid advancements in the nuclear field are anticipated to uplift India’s position in the global landscape in the coming years. The increasing investments in nuclear energy production are estimated to propel the demand for gadolinium components. For instance, the World Nuclear Association reveals that the country has around 23 operable nuclear reactors with 7,425 Mwe and 7 reactors with 5,398 Mwe under construction. The Nuclear Energy Mission under the Viksit Bharat Programme is further set to drive the gadolinium trade during the foreseeable period.
Nuclear Reactors Operating in India |
||||
Name |
Model |
Reactor Type |
Reference Unit Power (MWe) |
Grid Connection |
Kaiga 1 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2000-10 |
Kaiga 2 |
Horizontal Pressure Tube Type |
PHWR |
202 |
1999-12 |
Kaiga 3 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2007-04 |
Kaiga 4 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2011-01 |
Kakrapar 1 |
Horizontal Pressure Tube Type |
PHWR |
202 |
1992-11 |
Kakrapar 2 |
Horizontal Pressure Tube Type |
PHWR |
202 |
1995-03 |
Kakrapar 3 |
PHWR-700 |
PHWR |
630 |
2021-01 |
Kakrapar 4 |
PHWR-700 |
PHWR |
630 |
2024-02 |
Kudankulam 1 |
VVER V-412 |
PWR |
932 |
2013-10 |
Kudankulam 2 |
VVER V-412 |
PWR |
932 |
2016-08 |
Madras 1 |
Horizontal Pressure Tube Type |
PHWR |
205 |
1983-07 |
Madras 2 |
Horizontal Pressure Tube Type |
PHWR |
205 |
1985-09 |
Narora 1 |
Horizontal Pressure Tube Type |
PHWR |
202 |
1989-07 |
Narora 2 |
Horizontal Pressure Tube Type |
PHWR |
202 |
1992-01 |
Rajasthan 2 |
Horizontal Pressure Tube Type |
PHWR |
187 |
1980-11 |
Rajasthan 3 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2000-03 |
Rajasthan 4 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2000-11 |
Rajasthan 5 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2009-12 |
Rajasthan 6 |
Horizontal Pressure Tube Type |
PHWR |
202 |
2010-03 |
Tarapur 1 |
BWR-1 (Mark 2) |
BWR |
150 |
1969-04 |
Tarapur 2 |
BWR-1 (Mark 2) |
BWR |
150 |
1969-05 |
Tarapur 3 |
Horizontal Pressure Tube Type |
PHWR |
490 |
2006-06 |
Tarapur 4 |
Horizontal Pressure Tube Type |
PHWR |
490 |
2005-06 |
Source: World Nuclear Association

Companies Dominating the Gadolinium Market
- GE HealthCare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bracco S.p.A.
- Goodfellow Corporation
- GFS Chemicals, Inc.
- All-Chemie, Ltd
- Pascal Technologies, Inc.
- Fredericksburg
- Alfa Chemical Corporation
- Super Conductor Materials, Inc.
- Inorganic Ventures
- Molycorp Corporation
- Bayer AG
- Mallinckrodt Pharmaceuticals
- Taejoon Pharm Co., Ltd.
- J.B. Chemicals & Pharmaceuticals Ltd.
- Spago Nanomedical AB
- Isologic Innovative Radiopharmaceuticals
The leading companies in the gadolinium market are employing various strategies such as technological advancements, new product launches, partnerships & collaborations, mergers & acquisitions, and global expansion to earn high profits and maximize their reach. Organic marketing tactics aid in doubling the sales and revenue shares. Innovations in derivative formulations for use in several end use industries are further assisting key players to stand out in the crowd. Industry giants are also forming strategic partnerships with other players to introduce innovative solutions and attract a wider consumer base.
Some of the key players include:
In the News
- In April 2023, GE HealthCare introduced Pixxoscan (gadobutrol) a macrocyclic, non-ionic MRI gadolinium-based contrast agent (GBCA). Pixxoscan has been reviewed using a regulatory decentralized procedure commercialized in Austria and other European countries.
- In February 2023, Bracco S.p.A. announced the launch of the VUEWAY (gadopiclenol) injection. The Wellstar Health System was the first establishment to trial an FDA-approved macrocyclic gadolinium-based contrast agent VUEWAY injection for use in magnetic resonance imaging (MRI).
Author Credits: Rajrani Baghel
- Report ID: 7226
- Published Date: Feb 27, 2025
- Report Format: PDF, PPT